The World's Medicine Chest By Sally Pipes

The World's Medicine Chest

How America Achieved Pharmaceutical Supremacy - and How to Keep It

By Sally Pipes

Sally Pipes, the foremost expert on health care in America, has written a new book, THE WORLD'S MEDICINE CHEST: How America Achieved Pharmaceutical Supremacy - and How to Keep It, which details how America became the world's leader in biopharmaceutical innovation and reveals how new threats to this industry will have disastrous consequences for patients and the U.S. economy.

In the 1970s, Europe was the global hub for pharmaceutical innovation. European drug companies developed more than twice as many drugs in that decade as their U.S.-based counterparts. But times have changed. Today, nearly half of all new drugs come from the United States. Just 22 percent are of European origin. And U.S. patients get access to innovative medicines before anyone else in the world. The U.S. now leads the world in biopharmaceutical inventions. Around two-thirds of new drugs developed in the last decade or so originated in the United States.

In The World's Medicine Chest, you'll learn:

How Canada went wrong

          ·    How Canadian price controls work

·    Canada's price controls have deprived patients of access to critical medicines

About drug price controls - how price-setting damages innovation and costs us money

·    Price controls hinder innovation, harm patients, and cost us money

How the United States came to dominate the pharmaceutical industry

·    Rise of drug development in Europe

·    Rise of drug development in the U.S.

·    Downfall of European pharmaceutical industry - price controls

·    Price controls are actively killing drug development in Europe

About solutions - How to help more Americans afford their medicines without sacrificing future cures

·    Reforming the FDA

·    Reforming how we pay for drugs - "Big Ideas" project led by the Galen Institute

·    Defending U.S. patients from foreign freeloaders

How Trump can help Americans afford their medicines

Drawing on her decades of experience as a health policy scholar, Sally Pipes details how America became the world's leader in biopharmaceutical innovation. She argues that efforts over the last few years by Democrats and Republicans alike to impose price controls on prescription drugs will have disastrous consequences for patients and for the U.S. Economy.

SALLY C. PIPES is the Pacific Research Institute's president, CEO and Thomas W. Smith Fellow in Health Care policy who analyzes the latest health care trends and topics including single-payer, Obamacare, drug pricing and Medicare. A former Canadian, she's written about the health care policies in her native country that would bring harm to U.S. patients if imported across the border. Her latest book is "The World's Medicine Chest." She received an honorary PhD from Pepperdine University's School of Public Policy for her work on health care reform. Follow Pipes for continued insight on U.S. health care policy proposals, the dangers of government-run health care, and reforms to provide better quality and access to health care while lowering costs.